dacarbazine and Diffuse Parenchymal Lung Disease

dacarbazine has been researched along with Diffuse Parenchymal Lung Disease in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's3 (50.00)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Balzarini, L; Mancini, C; Marvisi, M1
Ishikawa, M; Oashi, K1
Autret-Leca, E; Beau Salinas, F; Carré, P; de Luca, K; Diot, P; Guilleminault, L; Narciso, B1
Carré, P; Diot, P; Guilleminault, L1
Lobrinus, JA; Matzinger, O; Michielin, O; Périard, D; Stupp, R; Udry, E1
Aisenberg, AC1

Reviews

1 review(s) available for dacarbazine and Diffuse Parenchymal Lung Disease

ArticleYear
Problems in Hodgkin's disease management.
    Blood, 1999, Feb-01, Volume: 93, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Cardiomyopathies; Clinical Trials as Topic; Cohort Studies; Combined Modality Therapy; Dacarbazine; Doxorubicin; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Infections; Laparotomy; Lung Diseases, Interstitial; Lymphography; Mechlorethamine; Middle Aged; Neoplasm Staging; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Prednisone; Procarbazine; Prognosis; Radiation Injuries; Radiotherapy; Remission Induction; Salvage Therapy; Vinblastine; Vincristine

1999

Other Studies

5 other study(ies) available for dacarbazine and Diffuse Parenchymal Lung Disease

ArticleYear
A fatal case of acute interstitial pneumonia (AIP) in a woman affected by glioblastoma.
    Current drug safety, 2014, Volume: 9, Issue:1

    Topics: Aged; Antineoplastic Agents, Alkylating; Blood Gas Analysis; Brain Neoplasms; Bronchoalveolar Lavage Fluid; Dacarbazine; Electrocardiography; Fatal Outcome; Female; Glioblastoma; Humans; Lung; Lung Diseases, Interstitial; Physical Examination; Pneumocystis carinii; Pneumonia, Pneumocystis; Temozolomide; Trimethoprim, Sulfamethoxazole Drug Combination

2014
Case of hypophysitis caused by nivolumab.
    The Journal of dermatology, 2017, Volume: 44, Issue:1

    Topics: Adrenal Insufficiency; Adrenocorticotropic Hormone; Anorexia; Antibodies, Monoclonal; Antineoplastic Agents; Conjunctiva; Dacarbazine; Hormone Replacement Therapy; Humans; Hydrocortisone; Hypophysitis; Hypothyroidism; Lung Diseases, Interstitial; Magnetic Resonance Imaging; Male; Melanoma; Middle Aged; Myalgia; Nausea; Nivolumab; Programmed Cell Death 1 Receptor; Withholding Treatment

2017
[Alveolo-interstitial pneumonia due to Temozolamide].
    Revue des maladies respiratoires, 2008, Volume: 25, Issue:7

    Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Bronchoalveolar Lavage; Dacarbazine; Female; Glioblastoma; Humans; Lung Diseases, Interstitial; Lymphocytosis; Middle Aged; Radiography, Thoracic; Temozolomide; Time Factors; Tomography, X-Ray Computed

2008
Hypersensitivity pneumonitis associated with temozolomide.
    The European respiratory journal, 2009, Volume: 34, Issue:2

    Topics: Alveolitis, Extrinsic Allergic; Biopsy; Brain; Dacarbazine; Dyspnea; Humans; Lung; Lung Diseases, Interstitial; Lymphocytes; Middle Aged; Prednisone; Pulmonary Fibrosis; Temozolomide

2009
Irinotecan-induced interstitial pneumonia.
    The Lancet. Oncology, 2004, Volume: 5, Issue:5

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Camptothecin; Dacarbazine; Diagnosis, Differential; Frontal Lobe; Glioblastoma; Humans; Irinotecan; Lung Diseases, Interstitial; Male; Radiography; Temozolomide

2004